OP0217 ANTI-RO52 ANTIBODIES ARE ASSOCIATED WITH HIGHER DISEASE SEVERITY IN PATIENTS WITH SJÖGREN DISEASE THROUGH ACTIVATION OF THE INTERFERON PATHWAY | Publicación